Close button
Enquiry IconContact Us
Logo

Intraosseous (IO) infusion involves injecting medication and fluids directly into the marrow of the bone by which rapid access to the vascular system can be gained. Intraosseous infusion offers several benefits when intravenous (IV) access is not possible and rapid vascular access is necessary. Moreover, any fluid or medication that can be administered through the IV route can be administered through the IO route as well. IO route offers the same or faster rate of drug/fluid administration as compared to IV route, and conditions such as cardiac arrest, arrhythmia, anaphylactic shock, and other commonly occurring medical conditions often require rapid medical attention and therapy administration.

The global intraosseous infusion devices market is estimated to be valued at US$ 916.9 Mn million in 2021 and is expected to exhibit a CAGR of 5.3% during the forecast period (2021-2028).

Figure 1.Global Intraosseous Infusion Devices Market Share (%) in Terms of Value, by Product Type, 2021

Intraosseous Infusion Devices  | Coherent Market Insights

Increasing prevalence of cardiovascular disorders is expected to drive the market growth during the forecast period.

The increasing incidences of cardiovascular disorders is expected to drive the market growth during the forecast period. For instance, in 2019, according to the World Health Organization (WHO), it was found that around 17.9 million individuals died from cardiovascular diseases, which is around 32% of the global deaths. 

CMI table icon

Intraosseous Infusion Devices Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 916.9 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 5.3% 2028 Value Projection: US$ 1,317.6 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: FAST1 Device, FASTx Device, Bone Injection Gun (BIG) Devices, EZ-IO Device, NIO Device, Dieckmann Modified Needle, Jamshidi Needle
  • By Technology: Manual IO Needles, Battery Powered Driver, Impact Driven Devices
  • By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Others (Pre-hospital Emergency Care, Military Hospitals
Companies covered:

PerSys Medical, Aero Healthcare AU Pty Ltd, Teleflex Incorporated, PAVmed Inc., BIOPSYBELL S.R.L., Becton Dickinson Company, Cook Group, SAM Medical, Argon Medical Devices, Inc., Cardinal Health, Inc., StarFish Product Engineering Inc., and Medax SRL unipersonle

Growth Drivers:
  • Increasing prevalence cardiovascular disorders
  • Advantages offered by intraosseous infusion technique
  • Technologically advanced product launches
Restraints & Challenges:
  • Presence of variety of alternative infusion options

Figure 2.Global Intraosseous Infusion Devices Market Share (%), by Technology, 2021

Intraosseous Infusion Devices  | Coherent Market Insights

Increasing technologically advanced product launches is expected to drive the market growth during the forecast period.

The increasing launches of advanced products is expected to drive the market growth during the forecast period. For instance, PAVmed, Inc., a multi-product, commercial-stage technology medical device company, had an implantable intraosseous vascular access device, ‘PortIO’ in the development phase. Moreover, in November 2019, PAVmed completed a pre-clinical animal study of PortIO, which documented an implant duration for over six months without any maintenance. The company secured a pre-submission meeting with the U.S. Food and Drug Administration (FDA) scheduled on January 8, 2020.

Global Intraosseous Infusion Devices Market– Impact of Coronavirus (COVID-19) Pandemic

Supply chain and manufacturing activities in India, Italy, Spain, U.K., and the U.S. have been disrupted due to lockdowns implemented by governments since the past few months, while countries such as Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation.

The coronavirus or COVID-19 outbreak that started from Wuhan, China has spread across continents, affecting various industries globally. Supply of key materials has been severely disrupted due to the forced quarantine, and lack of labor and raw materials. As the link between regional warehouses is not smooth, the transportation of raw materials between regions cannot be carried out successfully. This shortage of raw materials and components have affected the supply chain of the global intraosseous infusion devices market.

Moreover, the COVID-19 pandemic has impacted the global economy and in turn, the global intraosseous infusion devices market. Quarantines, traveling constraints, and social distancing measures are likely to lead to a steep decline in business and consumer spending.

Global Intraosseous Infusion Devices Market: Restraint

The major factor that hinders growth of the global intraosseous infusion devices market include presence of variety of alternative infusion options.

Key Players

Major players operating in the global intraosseous infusion devices market include PerSys Medical, Aero Healthcare AU Pty Ltd, Teleflex Incorporated, PAVmed Inc., BIOPSYBELL S.R.L., Becton Dickinson Company, Cook Group, SAM Medical, Argon Medical Devices, Inc., Cardinal Health, Inc., StarFish Product Engineering Inc., and Medax SRL unipersonle.

The intraosseous route offers immediate vascular access during emergency administration of drugs such as during resuscitation. Intraosseous (IO) access is the most frequently used route for emergency care of children and critically ill infants when IV access cannot be achieved rapidly. Intraosseous infusion uses the rich vascular network of bones to transport drugs and fluids from the medullary cavity to the circulation. The response and distribution of drugs and fluid injected by the intraosseous route appears to be very similar to intravenous injection. The procedure should be limited to emergency situations when intravenous access (including umbilical vein catheterization) cannot be established in a required length of time, usually 2-5 minutes. Moreover, sternal route for IO administration of medication has shown to improve patient outcomes as compared to humeral and tibial IO administration. Furthermore, use of IO infusion in critical settings such as for patients who are obese, hypovolemic, or have poor cardiac output, and in military settings is beneficial. In such patients, administration through the IV route becomes difficult to use.

Market Dynamics

The key players operating in the market are focusing on growth strategies such as acquisitions, which is expected to boost the growth of the global intraosseous infusion devices market over the forecast period. For instance, in May 2018, PerSys Medical, a company that provides emergency medical devices worldwide, announced the completion of acquisition of MAS Med Global for production of a new smart tourniquet called ADAM. This acquisition is a significant addition to PerSys Medical’s hemorrhage control portfolio.

Key features of the study:

  • This report provides in-depth analysis of the global intraosseous infusion devices market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global intraosseous infusion devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include PerSys Medical, Aero Healthcare AU Pty Ltd, Teleflex Incorporated, PAVmed Inc., BIOPSYBELL S.R.L., Becton Dickinson Company, Cook Group, SAM Medical, Argon Medical Devices, Inc., Cardinal Health, Inc., StarFish Product Engineering Inc., and Medax SRL unipersonle  
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global intraosseous infusion devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global intraosseous infusion devices market

Detailed Segmentation:

  • Global Intraosseous Infusion Devices market, By Product Type:
    • FAST1 Device
    • FASTx Device
    • Bone Injection Gun (BIG) Devices
    • EZ-IO Device
    • NIO Device
    • Dieckmann Modified Needle
    • Jamshidi Needle
  • Global Intraosseous Infusion Devices market, By Technology:
    • Manual IO Needles
    • Battery Powered Driver
    • Impact Driven Devices
  • Global Intraosseous Infusion Devices market, By End User:
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Others(Pre-hospital Emergency Care, Military Hospitals)
  • Global Intraosseous Infusion Devices market, By Region:
    • North America
      • Product Type
        • FAST1 Device
        • FASTx Device
        • Bone Injection Gun (BIG) Devices
        • EZ-IO Device
        • NIO Device
        • Dieckmann Modified Needle
        • Jamshidi Needle
      • Technology
        • Manual IO Needles
        • Battery Powered Driver
        • Impact Driven Devices
      • End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Others(Pre-hospital Emergency Care, Military Hospitals)
      • By Country
        • U.S.
        • Canada
    • Latin America
      • Product Type
        • FAST1 Device
        • FASTx Device
        • Bone Injection Gun (BIG) Devices
        • EZ-IO Device
        • NIO Device
        • Dieckmann Modified Needle
        • Jamshidi Needle
      • Technology
        • Manual IO Needles
        • Battery Powered Driver
        • Impact Driven Devices
      • End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Others(Pre-hospital Emergency Care, Military Hospitals)
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Product Type
        • FAST1 Device
        • FASTx Device
        • Bone Injection Gun (BIG) Devices
        • EZ-IO Device
        • NIO Device
        • Dieckmann Modified Needle
        • Jamshidi Needle
      • Technology
        • Manual IO Needles
        • Battery Powered Driver
        • Impact Driven Devices
      • End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Others(Pre-hospital Emergency Care, Military Hospitals)
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Product Type
        • FAST1 Device
        • FASTx Device
        • Bone Injection Gun (BIG) Devices
        • EZ-IO Device
        • NIO Device
        • Dieckmann Modified Needle
        • Jamshidi Needle
      • Technology
        • Manual IO Needles
        • Battery Powered Driver
        • Impact Driven Devices
      • End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Others(Pre-hospital Emergency Care, Military Hospitals)
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Product Type
        • FAST1 Device
        • FASTx Device
        • Bone Injection Gun (BIG) Devices
        • EZ-IO Device
        • NIO Device
        • Dieckmann Modified Needle
        • Jamshidi Needle
      • Technology
        • Manual IO Needles
        • Battery Powered Driver
        • Impact Driven Devices
      • End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Others(Pre-hospital Emergency Care, Military Hospitals)
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Product Type
        • FAST1 Device
        • FASTx Device
        • Bone Injection Gun (BIG) Devices
        • EZ-IO Device
        • NIO Device
        • Dieckmann Modified Needle
        • Jamshidi Needle
      • Technology
        • Manual IO Needles
        • Battery Powered Driver
        • Impact Driven Devices
      • End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Others(Pre-hospital Emergency Care, Military Hospitals)
      • By Region/Country
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • PerSys Medical
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Aero Healthcare AU Pty Ltd
    • Teleflex Incorporated
    • PAVmed Inc.
    • BIOPSYBELL S.R.L.
    • Becton Dickinson Company
    • Cook Group
    • SAM Medical
    • Argon Medical Devices, Inc.
    • Cardinal Health, Inc.
    • StarFish Product Engineering Inc.
    • Medax SRL unipersonle

 “*” marked represents similar segmentation in other categories in the respective section.

FAQ

Frequently Asked Questions

The global intraosseous infusion devices market size is estimated to be valued at US$ 916.9 million in 2021 and is expected to exhibit a CAGR of 5.3% between 2021 and 2028.

Factors such as the increasing incidences of cardiovascular disorders, advantages offered by intraosseous infusion technique, and technologically advanced product launches are expected to drive the growth of the market during forecast period.

EZ-IO device is the leading product type segment in the market.

The major factor hampering growth of the market include the presence of variety of alternative infusion options.

Major players operating in the market include PerSys Medical, Aero Healthcare AU Pty Ltd, Teleflex Incorporated, PAVmed Inc., BIOPSYBELL S.R.L., Becton Dickinson Company, Cook Group, SAM Medical, Argon Medical Devices, Inc., Cardinal Health, Inc., StarFish Product Engineering Inc., and Medax SRL unipersonle.

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly subscribe for our latest news & articles.